Luxme Nadarajah, Ian Butler, Holly Ciesielczuk, Jonathon Lambourne, Stanley Fan
{"title":"Culture-negative peritoneal dialysis-associated peritonitis rates are decreased with water lysis but not 16S rRNA gene sequencing.","authors":"Luxme Nadarajah, Ian Butler, Holly Ciesielczuk, Jonathon Lambourne, Stanley Fan","doi":"10.1177/08968608261493217","DOIUrl":"https://doi.org/10.1177/08968608261493217","url":null,"abstract":"<p><p>ObjectivesA successful peritoneal dialysis (PD) programme should aim to have low peritoneal dialysis-associated peritonitis (PDAP) rates. Identification of the microbial organism enables targeted antibiotic treatment and allows for a root cause analysis to be performed. Culture-negative (CN) peritonitis presents a more challenging scenario whereby empirical treatment for Gram-positive and Gram-negative organisms is commenced for 14 days, with Gram-negative cover discontinued based upon clinical response. In accordance with ISPD recommendations, we conducted a clinical quality improvement project in 2018 to decrease our culture-negative PDAP.MethodsFrom 2018 to 2021, our department had 336 cases of PDAP. The introduction of a water-lysis step and the application of 16S rRNA gene sequencing were implemented to reduce culture-negative PDAP.ResultsThere were 336 cases of PDAP between 2018 and 2021. In total, 135 cases occurred prior to the initiation of the water lysis step and 201 cases occurred after the introduction of the water lysis step and 16S rRNA sequencing. The rate of culture-negative PDAP prior to our change in PD effluent culture methodology was 33% (45/135); following changes to include a water lysis step and an increase in sample volume, the rate of culture-negative PDAP significantly fell to 20% (41/201) (<i>p</i> < 0.01). 16S rRNA, using Sanger sequencing of culture-negative samples, did not significantly increase pathogen detection. Five out of 6 samples remained CN in the pre-water lysis step group, and 17 out of 23 samples also remained CN in the post-water lysis group (<i>p</i> = 0.61).ConclusionsIntroduction of water lysis of peritoneal effluent significantly decreased culture-negative peritonitis rates, thus increasing organism identification and allowing for targeted antimicrobial therapy.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261493217"},"PeriodicalIF":1.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yung-An Chen, Yi-Chih Lin, Yu-Hsiang Chou, Yi-Ting Chen, Shuei-Liong Lin
{"title":"The clinical impact of burnout among peritoneal dialysis patients.","authors":"Yung-An Chen, Yi-Chih Lin, Yu-Hsiang Chou, Yi-Ting Chen, Shuei-Liong Lin","doi":"10.1177/08968608261502214","DOIUrl":"https://doi.org/10.1177/08968608261502214","url":null,"abstract":"<p><p>BackgroundPeritoneal dialysis (PD) requires intensive daily self-management and may impose a substantial psychological burden on patients. However, the prevalence of burnout among PD patients and its association with clinical outcomes remain unclear. This study investigated the prevalence of burnout and anxiety among patients undergoing PD and their associations with clinical outcomes.MethodsIn this prospective observational cohort study, patients undergoing PD at National Taiwan University Hospital were assessed using the Maslach Burnout Inventory, and the State-Trait Anxiety Inventory. Patients were followed for transfer to hemodialysis (HD) and all-cause mortality. Associations were evaluated using multivariable Cox proportional hazards models.ResultsAmong 183 patients who completed the questionnaires, 24.0% had emotional exhaustion and 19.7% had severe anxiety. During follow-up, high cynicism was associated with an increased risk of transfer to HD. In the age- and sex-adjusted Cox proportional hazards model, high cynicism remained significantly associated with transfer to HD (adjusted hazard ratio (HR), 3.47; 95% CI, 1.14-10.58; <i>p</i> = .029). In contrast, the association between high cynicism and all-cause mortality was attenuated after adjustment for age and sex and did not reach statistical significance (adjusted HR, 3.80; 95% CI, 0.78-18.58; <i>p</i> = .099).ConclusionsBurnout and anxiety are common among patients undergoing PD. High cynicism was independently associated with an increased risk of transfer to HD, highlighting the potential importance of psychological well-being in PD care.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261502214"},"PeriodicalIF":1.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The protective role of nicotinamide N-methyltransferase and its metabolite 1-methylnicotinamide in peritoneal fibrosis.","authors":"Qiongya Wang, Yutao Chen, Tingting Guo, Congwei Luo, Qianyin Huang, Wanyu Yang, Lichun Hong, Junjie Bai, Xun Tang, Jun Zhang","doi":"10.1177/08968608261502212","DOIUrl":"https://doi.org/10.1177/08968608261502212","url":null,"abstract":"<p><p>BackgroundLong-term exposure to bioincompatible peritoneal dialysis (PD) solutions can cause peritoneal fibrosis (PF) and progressive loss of peritoneal membrane function. This study investigated the effects of nicotinamide N-methyltransferase (NNMT) and its metabolite 1-methylnicotinamide (MNAM) in experimental PF and examined their association with Cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) expression.MethodsA rat model of PF was established using high-glucose PD fluid combined with lipopolysaccharide, and primary rat peritoneal mesothelial cells (RPMCs) were stimulated with transforming growth factor-β1 (TGF-β1). The effects of NNMT overexpression and exogenous MNAM administration were evaluated using peritoneal equilibration testing, histological analysis, quantitative real-time polymerase chain reaction, and western blot analysis.ResultsNNMT expression was decreased in TGF-β1-stimulated RPMCs and fibrotic rat peritoneal tissues. NNMT overexpression reduced fibrosis-related marker expression in RPMCs and attenuated peritoneal thickening, extracellular matrix deposition, and functional alterations in PF rats. Exogenous MNAM administration also reduced fibrotic changes and partially improved peritoneal transport parameters in PF rats. NNMT overexpression was accompanied by increased cGAS and STING expression in both models; however, pathway activity and functional involvement were not directly examined.ConclusionNNMT and MNAM exert protective effects in experimental PF. The association between NNMT overexpression and altered cGAS and STING expression requires further mechanistic investigation. The NNMT/MNAM metabolic axis may represent a potential therapeutic target for PF.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261502212"},"PeriodicalIF":1.8,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From haemodialysis to peritoneal dialysis and back: A patient and family perspective on time on peritoneal dialysis.","authors":"Brenda Borg, Emely Borg, Karine Manera","doi":"10.1177/08968608261504152","DOIUrl":"https://doi.org/10.1177/08968608261504152","url":null,"abstract":"","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261504152"},"PeriodicalIF":1.8,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reducing dialysis system fragility in Japan by expanding and strengthening peritoneal dialysis: Lessons learned from the Great East Japan earthquake.","authors":"Takefumi Mori, Yukari Kikuchi, Hiroki Ito, Katsuya Ishiyama, Ikuko Oba-Yabana, Takuo Hirose, Tsutomu Onishi, Tomoyoshi Kimura","doi":"10.1177/08968608261500587","DOIUrl":"https://doi.org/10.1177/08968608261500587","url":null,"abstract":"","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261500587"},"PeriodicalIF":1.8,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149272250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana E Figueiredo, Josephine Sf Chow, Ilaria de Barbieri, Carlos Eduardo Poli-de-Figueiredo
{"title":"Use of the face mask in peritoneal dialysis: Analysis of an online survey on global practices.","authors":"Ana E Figueiredo, Josephine Sf Chow, Ilaria de Barbieri, Carlos Eduardo Poli-de-Figueiredo","doi":"10.1177/08968608261497319","DOIUrl":"https://doi.org/10.1177/08968608261497319","url":null,"abstract":"<p><p>Peritoneal dialysis (PD) is an established home-based therapy. Face masks have historically been used as an infection-prevention measure during PD exchanges, although their effectiveness remains uncertain. Current evidence emphasizes hand hygiene and aseptic technique, while the incremental benefit of routine face mask use has not been clearly established. We conducted a cross-sectional online survey of PD nurses and nephrologists to describe clinical practices regarding face mask use during PD exchanges. Participants were recruited through professional networks and international professional organizations. The survey included questions regarding patient and healthcare professional mask use, institutional guidance, patient training, and perceptions of effectiveness. A total of 733 healthcare professionals from 71 countries responded, including 617 nurses (84.2%). Face masks were reported to be always used by patients during bag exchanges or connection to the cycler by 72.3% (n = 530) of respondents. The most frequently reported reason for mask use was general infection prevention (40.9%, n = 299). Mask use was included in patient training by 80.2% (n = 588), and 77.6% (n = 567) believed that mask use helps prevent peritonitis. Significant regional differences were observed in reported mask-use practices (χ<sup>2</sup> = 44.65, df = 8, p < 0.001). Mask use also varied according to PD program size (χ<sup>2</sup> = 20.06, df = 6, p = 0.003). In addition, 39.6% (n = 290) reported that their facility followed specific guidance regarding mask use. Routine face mask use remains common in PD practice and is widely incorporated into patient training. Substantial regional and program-size variation was observed. Given the limited and uncertain evidence regarding the incremental benefit of routine mask use, these findings describe substantial variation in current practice and highlight the need for further evidence to clarify the role of face masks in PD infection prevention.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261497319"},"PeriodicalIF":1.8,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Arunima Jain, Matthew Rowlandson, Eric Au, Sradha Kotwal, David W Johnson, Kamal Sud, Katrina Chau, Ashik Hayat, Monique Borlace, Melinda Tomlins, Dana Forcey, Yeoungjee Cho, Jenny Hc Chen, Neil Boudville
{"title":"Temporal association of peritoneal dialysis-associated peritonitis rates and outcomes with COVID-19 pandemic onset in Australia: A registry analysis.","authors":"Arunima Jain, Matthew Rowlandson, Eric Au, Sradha Kotwal, David W Johnson, Kamal Sud, Katrina Chau, Ashik Hayat, Monique Borlace, Melinda Tomlins, Dana Forcey, Yeoungjee Cho, Jenny Hc Chen, Neil Boudville","doi":"10.1177/08968608261469965","DOIUrl":"https://doi.org/10.1177/08968608261469965","url":null,"abstract":"<p><p>BackgroundEffective infection control practices are recommended to prevent peritoneal dialysis-associated peritonitis (PD peritonitis). Effects of the coronavirus 2019 (COVID-19) pandemic and preventive measures on PD peritonitis outcomes are unclear.MethodsUsing the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry data, we assessed PD peritonitis rates and outcomes in Australia before and after COVID-19 pandemic onset, defined using the World Health Organisation pandemic date (11/03/2020), between 01/01/2015 and 31/12/2022. PD peritonitis rates, trends (using interrupted time series and joinpoint regression analysis) and outcomes were analysed in prevalent patients on PD. Incident and prevalent patient characteristics commencing PD were analysed.ResultsIn prevalent PD patients (<i>n</i> = 11,499), peritonitis rates were lower post-COVID-19 (0.30 episodes per patient-year, 95% confidence interval [CI]: 0.29-0.31) than in the pre-COVID-19 period (0.35, 95% CI: 0.34-0.36, <i>p</i> < 0.001). PD peritonitis rates were declining prior to COVID-19 (incident rate ratio [IRR] per half-year = 0.97, 95% CI 0.96-0.98, <i>p</i> < 0.001), with a relative increase after COVID-19 onset (IRR = 1.05; 95% CI: 1.00-1.09, <i>p</i> = 0.049).There were increases in odds of PD peritonitis relapse (adjusted odds ratio (aOR): 1.41, 95% CI: 1.14-1.76) and recurrence (aOR: 1.45, 95% CI: 1.13-1.86) post-COVID-19.A total of 8999 incident patients started PD during the study period, 5763 pre-COVID-19 and 3236 post-COVID-19. Patient characteristics were similar between groups, other than rates of smoking, cerebrovascular disease and PD modality.ConclusionsPD peritonitis rates have been declining in Australia, with a modest relative increase in peritonitis rates post-COVID-19 onset. Odds of PD peritonitis relapse and recurrence were higher post-COVID-19, highlighting the need for further research regarding PD practices post-pandemic.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261469965"},"PeriodicalIF":1.8,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149147803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Niakhaleen Keita, Niokhor Diaw, Ahmed Tall Lemrabott, Moustapha Faye, Ibrahima Sow, Fatou Ndiaye, Bacary Ba, Maria Faye, Fatou Gueye, Mame Awa Diop, Mansour Mbengue, Abdou Niang, El Hadji Fary Ka
{"title":"Long-term clinical outcomes of peritoneal dialysis patients: analysis of the Senegalese cohort from 2004 to 2020.","authors":"Niakhaleen Keita, Niokhor Diaw, Ahmed Tall Lemrabott, Moustapha Faye, Ibrahima Sow, Fatou Ndiaye, Bacary Ba, Maria Faye, Fatou Gueye, Mame Awa Diop, Mansour Mbengue, Abdou Niang, El Hadji Fary Ka","doi":"10.1177/08968608261493211","DOIUrl":"https://doi.org/10.1177/08968608261493211","url":null,"abstract":"<p><p>BackgroundPeritoneal dialysis (PD) was introduced in Senegal in 2003, with the first PD center established at Aristide Le Dantec University Hospital. Our study aims to determine long-term outcomes of the Senegalese PD cohort.MethodsWe performed a single-center retrospective cohort study of adults patients treated with chronic PD from 2004 to 2020. Demographics, comorbidities, labs, complications, hemodialysis (HD) transfers, hospitalizations, PD discontinuation and mortality were collected. Survival was assessed using Kaplan-Meier and Cox models.ResultsDuring the study period, 232 patients were treated by PD. The mean age was 47.5 ± 14.9 years, 56.9% were female, 76% lacked health insurance, and 98.3% had hypertension. Median distance to the PD unit was 22 km (IQR: 13-100). Most patients started kidney replacement therapy on HD in private sector and were transferred to PD due to financial constraints (out-of-pocket payment). A total of 351 peritonitis episodes occurred in 174 patients (0.97 episodes per patient-year), including 14.9% experienced more than three episodes. <i>Staphylococcus aureus</i> and <i>Pseudomonas</i> species were the most frequent causative organisms, with 35.9% of culture-negative episodes. Permanent transfer to HD was the leading cause of PD discontinuation (59.6%), followed by death (37.7%). Median patient survival was 31 months. Time on PD therapy had a median of 35 months, with one-, three-, and five-year survival of 86.1%, 49.8%, and 25.3%, respectively, censored for death, kidney transplantation, and recovery of renal function.ConclusionsPD in Senegal is suitable but challenged by infectious, mechanical, metabolic complications and socioeconomic barriers. Improving infection control, monitoring, catheter placement, and insurance coverage is key to expanding equitable dialysis access.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261493211"},"PeriodicalIF":1.8,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149137864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wai Lun Will Pak, Desmond Yat Hin Yap, Shui Kuen Cheng, Sandy Ka Yee Chau, Chi Kwan Lam, Sze Ho Sunny Wong
{"title":"<i>Stenotrophomonas maltophilia</i> peritoneal dialysis-related peritonitis: A 20-year single-centre retrospective review.","authors":"Wai Lun Will Pak, Desmond Yat Hin Yap, Shui Kuen Cheng, Sandy Ka Yee Chau, Chi Kwan Lam, Sze Ho Sunny Wong","doi":"10.1177/08968608261493212","DOIUrl":"https://doi.org/10.1177/08968608261493212","url":null,"abstract":"<p><p>BackgroundPeritoneal dialysis (PD)-related peritonitis due to <i>Stenotrophomonas maltophilia</i> presents significant challenges in clinical management due to its multi-drug resistance and tendency to form biofilms. Published data on its clinical epidemiology and outcomes remain limited.MethodsWe retrospectively reviewed all <i>S. maltophilia</i> PD-peritonitis at a regional PD centre in Hong Kong from April 2005 to March 2025. Patient characteristics, antimicrobial sensitivity and resistance patterns, treatments, and outcomes were analysed.ResultsWe identified 28 <i>S. maltophilia</i> peritonitis episodes in 27 patients during the study period, accounting for 0.96% of all peritonitis episodes. Nineteen (70.4%) patients had medical comorbidities suggesting immunocompromised states in addition to chronic kidney disease; most episodes occurred after hospitalization (64.3%) or antibiotic use (57.1%). While most initial isolates were susceptible to trimethoprim-sulfamethoxazole (100%), levofloxacin (96.3%), and minocycline (100%), later emergence of less susceptible isolates was common (42.9%). Six episodes (21.4%) achieved medical cure but 9 (32.1%) showed relapsing peritonitis. Fifteen (53.6%) experienced PD catheter removal while 12 (42.9%) required transfer to haemodialysis. Eight (28.6%) had peritonitis-associated death.ConclusionThis is the largest case series of <i>S. maltophilia</i> PD-peritonitis to date. <i>S. maltophilia</i> was an uncommon cause of PD-peritonitis but conferred substantial adverse outcomes. Early identification of <i>S. maltophilia</i> and sufficient duration of appropriate antimicrobials may help achieve better outlook.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261493212"},"PeriodicalIF":1.8,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149137923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Silvio Borrelli, Valentina Masola, Tommaso Prosdocimi, Richard Corbett, Francesco Trepiccione, Lorenzo Di Liberato, Mario Bonomini, Gaetano La Manna, Giacomo Magnoni, Luca Nardelli, Giuseppe Castellano, Giuseppe Paribello, Federica Marzano, Luciano D'Apolito, Sarah Lawman, Valerio Vizzardi, Gianpaolo Reboldi, Josè Carolino Divino-Filho, Giovambattista Capasso, Massimo Iacobelli, Arduino Arduini
{"title":"PolyCore, a bimodal peritoneal dialysis solution based on xylitol, L-carnitine, and icodextrin: In vitro evidence of the peritoneal membrane protection, rationale, and design of the phase II pilot study EXCITE.","authors":"Silvio Borrelli, Valentina Masola, Tommaso Prosdocimi, Richard Corbett, Francesco Trepiccione, Lorenzo Di Liberato, Mario Bonomini, Gaetano La Manna, Giacomo Magnoni, Luca Nardelli, Giuseppe Castellano, Giuseppe Paribello, Federica Marzano, Luciano D'Apolito, Sarah Lawman, Valerio Vizzardi, Gianpaolo Reboldi, Josè Carolino Divino-Filho, Giovambattista Capasso, Massimo Iacobelli, Arduino Arduini","doi":"10.1177/08968608261493817","DOIUrl":"https://doi.org/10.1177/08968608261493817","url":null,"abstract":"<p><p>BackgroundGlucose exposure in peritoneal dialysis contributes to local peritoneal membrane injury and systemic metabolic complications. The osmo-metabolic approach seeks to reduce glucose burden by using alternative osmotic agents such as xylitol and L-carnitine. PolyCore is a novel glucose-free bimodal peritoneal dialysis solution combining icodextrin (4%), xylitol (1.5%), and L-carnitine (0.02%), designed to provide sustained ultrafiltration while improving biocompatibility.MethodsHuman peritoneal mesothelial cells were exposed to PolyCore, icodextrin 7.5% solution, or a control medium. Cell viability, transepithelial electrical resistance, fibrosis-related gene expression, and α-SMA (alpha-smooth muscle actin) protein expression were assessed. In parallel, the EXCITE study was designed as a phase II, single-arm, prospective pilot trial evaluating PolyCore in 28 adults with end-stage kidney disease receiving incremental peritoneal dialysis.ResultsPolyCore preserved mesothelial cell viability and barrier integrity, with transepithelial resistance values comparable to control and significantly higher than icodextrin 7.5%. Compared with icodextrin 7.5%, PolyCore showed a more favorable expression profile of mesothelial-to-mesenchymal transition markers, with lower α-SMA and vimentin and preserved E-cadherin. The EXCITE study will assess safety and preliminary efficacy, including dialysis adequacy, ultrafiltration, solute removal, metabolic parameters, and patient-reported outcomes.ConclusionsPolyCore showed favorable in vitro biocompatibility compared with standard icodextrin 7.5% and may represent a glucose-free bimodal strategy for peritoneal dialysis. EXCITE will provide first clinical assessment on the safety and preliminary efficacy of PolyCore.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261493817"},"PeriodicalIF":1.8,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149137926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}